Journal
/
Immunology and Infection
/
ve Cefoperazone-tedavi edilmiş fare modeli klinik olarak ilgili<em> Clostridium difficile</em> Gerilme R20291
JoVE Journal
Immunology and Infection
A subscription to JoVE is required to view this content.  Sign in or start your free trial.
JoVE Journal Immunology and Infection
Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291
Please note that all translations are automatically generated. Click here for the English version.

ve Cefoperazone-tedavi edilmiş fare modeli klinik olarak ilgili<em> Clostridium difficile</em> Gerilme R20291

Türkçe

Automatically Generated

12,056 Views

•

06:51 min

•

December 10, 2016

DOI:

10.3791/54850-v

DOI:
10.3791/54850-v

•

06:51 min
December 10, 2016

•

5 Views
, , ,
1Department of Population Health and Pathobiology,North Carolina State University College of Veterinary Medicine, 2Department of Pathology and Laboratory Medicine, Lineberger Comprehensive Cancer Center,University of North Carolina School of Medicine

Summary

Automatically generated

Bu protokol klinik olarak ilgili ve genetik uysal gerginlik, R20291 kullanarak Clostridium difficile enfeksiyonu (CDI) sefoperazon fare modeli özetliyor. Klinik hastalık izleme, C. difficile bakteriyel numaralandırma, toksin sitotoksisite ve bir fare modelinde CDI genelinde histopatolojik değişikliklere vurgu protokolde ayrıntılı olarak verilmiştir.

Explore More Videos

Clostridium DifficileMouse ModelCefoperazoneSpore InoculumGavageAnaerobicDilutionEnumerationToxin CytotoxicityHistopathology

Read Article

Cite this Article

Winston, J. A., Thanissery, R., Montgomery, S. A., Theriot, C. M. Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291. J. Vis. Exp. (118), e54850, doi:10.3791/54850 (2016).

Download .ris file

Copy

Share Video

.

Copy